Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study
<title>Extract</title> Interstitial lung diseases (ILDs) are disorders characterized by fibrosis with varying inflammation [1]. With population ageing, ILD prevalence is increasing alongside the overall cancer burden, with increasing attention to the association between ILD and lung cancer. Shared risk factors including smoking and environmental exposures are unlikely to fully explain this relationship [2]. Proposed mechanisms include genetic predisposition, chronic inflammation, recurrent alveolar injury, and a pro-fibrotic microenvironment [3].
Authors
- Morten Bendixen (ORCID: https://orcid.org/0000-0003-4010-0885)
- Jan Brink Valentin (ORCID: https://orcid.org/0000-0002-8205-7179)
- Anne Gulbech Ording (ORCID: https://orcid.org/0000-0002-8073-7664)
- Elisabeth Bendstrup (ORCID: https://orcid.org/0000-0002-4238-6963)
- Jesper Rømhild Davidsen (ORCID: https://orcid.org/0000-0003-4128-4014)
- Jakob Nebeling Hedegaard (ORCID: https://orcid.org/0009-0001-0714-7334)
- Christian Borbjerg Laursen (ORCID: https://orcid.org/0000-0001-6382-9906)
- Thomas Decker Christensen (ORCID: https://orcid.org/0000-0001-6509-8510)
Institutions
- University of Southern Denmark (DK)
- Aarhus University (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Lillebaelt Hospital (DK)
- Aalborg University (DK)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2026-07-02
- DOI
- https://doi.org/10.1183/13993003.00525-2026
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kræftens Bekæmpelse